8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2013 / Systematic review and meta-analysis
A systematic review and meta-analysis of eight studies with 61,386 participants and 3,988 events evaluated metabolic status and BMI categories. In studies with at least 10 years of follow-up, metabolically healthy obesity was associated with higher risk of mortality or cardiovascular events compared to metabolically healthy normal weight (RR 1.24; 95% CI 1.02 to 1.55). All metabolically unhealthy groups also demonstrated heightened risk.
Kramer CK, Zinman B, Retnakaran R Ann Intern Med, 2013. PMID 24297192
2013 / Meta-analysis of randomized controlled trials
A meta-analysis of five randomized controlled trials assessed saffron supplementation for major depressive disorder. Saffron significantly reduced depressive symptoms compared with placebo (mean effect size = 1.62, P < 0.001 across 2 trials). Compared with standard antidepressants across 3 trials, saffron showed a null effect size (mean effect size = -0.15), indicating similar efficacy in mitigating depressive symptoms.
Hausenblas HA, Saha D, Dubyak PJ, et al. J Integr Med, 2013. PMID 24299602
2013 / Systematic review and dose-response meta-analysis of cohort studies
A systematic review and random-effects dose-response meta-analysis of 22 prospective cohort study publications evaluated dietary fibre intake and cardiovascular outcomes. Total dietary fibre intake was inversely associated with risk of cardiovascular disease (risk ratio 0.91 per 7 g/day [95% CI 0.88 to 0.94]; I2=45%) and coronary heart disease (0.91 [0.87 to 0.94]; I2=33%). Insoluble fibre and fibre from cereal and vegetable sources were inversely associated with both cardiovascular disease and coronary heart disease risk, while fruit fibre intake was inversely associated with cardiovascular disease risk.
Shows an association, not proof of cause and effect.
Threapleton DE, Greenwood DC, Evans CE, et al. BMJ, 2013. PMID 24355537
2013 / Network meta-analysis of randomised controlled trials
A network meta-analysis evaluated 305 randomised controlled trials with 339,274 participants across 16 meta-analyses and three recent trials to compare exercise and drug interventions on mortality. No statistically detectable differences were observed between exercise and drug interventions in the secondary prevention of coronary heart disease and prediabetes. For stroke rehabilitation, exercise was more effective than anticoagulants (OR 0.09, 95% CrI 0.01 to 0.70) and antiplatelets (OR 0.10, 95% CrI 0.01 to 0.62), whereas diuretics were more effective than exercise in heart failure (OR 4.11, 95% CrI 1.17 to 24.76).
Naci H, Ioannidis JP BMJ, 2013. PMID 24473061
2012 / Bayesian meta-analysis of randomized controlled trials
A Bayesian meta-analysis of 17 randomized controlled trials evaluated the effect of isoflavone-containing soy products on endothelial function measured by FMD. The overall mean absolute change in FMD for isoflavone-containing soy product interventions was 1.15% (95% Bayesian CI: -0.52, 2.75). When analyzed separately, isolated isoflavones showed a treatment effect of 1.98% (95% Bayesian CI: 0.07, 3.97), whereas isoflavone-containing soy protein showed 0.72% (95% Bayesian CI: -1.39, 2.90). Models were not improved by accounting for cuff measurement location, dietary modifications, or baseline FMD.
Beavers DP, Beavers KM, Miller M, et al. Nutr Metab Cardiovasc Dis, 2012. PMID 20709515
2012 / Meta-analysis of randomized controlled trials
A meta-analysis of 11 randomized controlled trials evaluated the effect of dietary soy isoflavones on blood pressure. Overall, soy isoflavones resulted in a mean decrease of 2.5 mm Hg (95% CI: -5.35 to 0.34, P = 0.08) for systolic blood pressure (SBP) and 1.5 mm Hg (95% CI: -3.09 to 0.17, P = 0.08) for diastolic blood pressure (DBP) compared to placebo. In subgroup analyses of hypertensive subjects (5 trials), soy isoflavones significantly reduced SBP by -5.94 mm Hg (95% CI: -10.55 to -1.34, P = 0.01) and DBP by -3.35 mm Hg (95% CI: -6.52 to -0.19, P = 0.04). No significant reduction was found in normotensive subjects (6 trials; SBP: 0.29 mm Hg, P = 0.83; DBP: -0.43 mm Hg, P = 0.50). Authors noted larger trials are needed to confirm the findings.
Liu XX, Li SH, Chen JZ, et al. Nutr Metab Cardiovasc Dis, 2012. PMID 21310599
2012 / Systematic review and secular trend analysis
A systematic review examined historical sleep duration data among children aged 5-18 years across 20 countries from 1905 to 2008. Using raw data and pseudodata generated via Monte Carlo simulation, 641 linear regressions were derived. The sample-weighted median rate of change was -0.75 min nightly per year, totaling a decrease of over 1 hour per night across the period. Declines occurred across age, sex, and day type categories, with decreases noted in Europe, the USA, Canada, and Asia, while Australia, the UK, and Scandinavia showed increases.
Shows an association, not proof of cause and effect.
Matricciani L, Olds T, Petkov J Sleep Med Rev, 2012. PMID 21612957
2012 / Systematic review and meta-analysis of prospective cohort studies
A systematic review and meta-analysis of 19 prospective cohort studies evaluated the dose-response relationship between dairy products and colorectal cancer risk. The summary relative risk was 0.83 (95% CI: 0.78-0.88, I2=25%) per 400 g/day of total dairy products, 0.91 (95% CI: 0.85-0.94, I2=0%) per 200 g/day of milk, and 0.96 (95% CI: 0.83-1.12, I2=28%) per 50 g/day of cheese. Inverse associations were seen in both men and women but were restricted to colon cancer. There was evidence of a nonlinear association for milk and total dairy products (P<0.001), with inverse associations appearing strongest at higher intake ranges.
Shows an association, not proof of cause and effect.
NANO counterpoint →
Aune D, Lau R, Chan DSM, et al. Ann Oncol, 2012. PMID 21617020
2012 / Systematic review
A systematic review evaluated 101 studies and reports on copper, iron, and Alzheimer's disease. Eleven interventional trials supplementing or depleting these minerals failed to demonstrate cognitive benefits in patients with Alzheimer's disease. Prospective observational evidence linked cognitive decline to diets simultaneously elevated in copper and saturated fatty acids. Brain iron was elevated in Alzheimer's cases, whereas copper was predominantly unchanged in brain tissue but elevated in serum.
Loef M, Walach H Br J Nutr, 2012. PMID 21767446
2012 / Systematic review and meta-analysis of cohort studies
A systematic review and meta-analysis of six longitudinal cohort studies examined the relationship between dietary lutein and zeaxanthin intake and age-related macular degeneration (AMD) risk. Comparing the highest with the lowest intake categories, the pooled relative risk was 0.96 (95% CI 0.78, 1.17) for early AMD. Intake was significantly linked to a reduced risk of late AMD (RR 0.74; 95% CI 0.57, 0.97) and neovascular AMD (RR 0.68; 95% CI 0.51, 0.92).
Shows an association, not proof of cause and effect.
Ma L, Dou HL, Wu YQ, et al. Br J Nutr, 2012. PMID 21899805
2012 / Meta-analysis of randomized controlled trials
A meta-analysis evaluated 13 randomized, placebo-controlled trials with 731 participants investigating omega-3 fatty acids for major depressive disorder. Omega-3 treatment demonstrated no significant benefit over placebo for depression severity (SMD = 0.11, 95% CI: -0.04 to 0.26). After adjusting for significant publication bias using the trim-and-fill method, the effect was further diminished (SMD = 0.01, 95% CI: -0.13 to 0.15).
Bloch MH, Hannestad J Mol Psychiatry, 2012. PMID 21931319
2012 / Systematic review and meta-analysis of observational studies
A systematic review and meta-analysis of 15 cohort studies and 2 case-control studies evaluated major congenital malformations (MCM) in offspring of women with gestational diabetes mellitus (GDM) compared to a reference population. A higher risk of MCM was observed in offspring of women with GDM, with an RR of 1.16 (95% CI 1.07-1.25) in cohort studies and an OR of 1.4 (95% CI 1.22-1.62) in case-control studies. For women with pregestational diabetes, the risk was higher: RR 2.66 (95% CI 2.04-3.47) in cohort studies and OR 4.7 (95% CI 3.01-6.95) in the single available case-control study. The authors noted that the contribution of women with overt hyperglycemia and other factors could not be ascertained.
Shows an association, not proof of cause and effect.
Balsells M, García-Patterson A, Gich I, et al. Diabetes Metab Res Rev, 2012. PMID 22052679
2012 / Systematic review and meta-analysis of randomized controlled trials
This study reviewed randomized controlled trial (RCT) evidence to clarify adverse events related to calcium supplementation and examine self-reported myocardial infarction (MI). In seven RCTs, self-reported gastrointestinal (GI) adverse event rates were significantly more common with calcium (14.1%) than placebo (10.0%; RR 1.43, 95% CI 1.28-1.59, p < 0.001). Adjudicated functional GI hospitalizations in one study were 6.8% with calcium versus 3.6% with placebo (RR 1.92, 95% CI 1.21-3.05, p = 0.006). In two trials comparing self-reported and adjudicated MI, self-reported MI was 3.6% with calcium and 2.1% with placebo, but after adjudication rates were 2.4% vs. 1.6% (RR 1.45, 95% CI 0.88-2.45, p = 0.145).
Lewis JR, Zhu K, Prince RL J Bone Miner Res, 2012. PMID 22139587
2012 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis evaluated 19 randomized, placebo-controlled trials of homocysteine-lowering supplementation with vitamins B6, B12, and folic acid. B-vitamin supplementation did not improve cognitive function in individuals with cognitive impairment (SMD 0.10, 95% CI -0.08 to 0.28) or without cognitive impairment (SMD -0.03, 95% CI -0.1 to 0.04). Findings remained null regardless of study duration, trial sample size, or national folate status.
Ford AH, Almeida OP J Alzheimers Dis, 2012. PMID 22232016
2012 / Systematic review and meta-analysis of prospective studies
A systematic review and meta-analysis of 16 prospective studies was conducted to evaluate fiber intake and breast cancer risk. Comparing the highest versus lowest intake, the summary relative risk was 0.93 (95% CI 0.89-0.98) for dietary fiber and 0.91 (95% CI 0.84-0.99) for soluble fiber, with non-significant associations for fruit, vegetable, cereal, and insoluble fiber. Each 10 g/day increase in dietary fiber was associated with a summary RR of 0.95 (95% CI 0.91-0.98). In stratified analyses, the inverse association was observed only among studies with a large range (≥13 g/day) or high level of intake (≥25 g/day).
Shows an association, not proof of cause and effect.
Aune D, Chan DS, Greenwood DC, et al. Ann Oncol, 2012. PMID 22234738
2012 / Meta-analysis of prospective cohorts
In a meta-analysis of 7 prospective studies with 10 cohorts (268,718 participants and 1,474 events followed for 6-15 years), high and moderately high versus low salt intake were associated with gastric cancer risk (RR 1.68, 95% CI 1.17-2.41, p = 0.005, and RR 1.41, 95% CI 1.03-1.93, p = 0.032). The link was stronger in Japanese cohorts, and consumption of selected salt-rich foods showed a similar positive association.
Shows an association, not proof of cause and effect.
D'Elia L, Rossi G, Ippolito R, et al. Clin Nutr, 2012. PMID 22296873
2012 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 42 RCTs involving 1,297 participants assessed the cardiovascular effects of chocolate, cocoa, and flavan-3-ols. Intake improved HOMA-IR (-0.67; 95% CI: -0.98, -0.36) via reductions in serum insulin, and enhanced FMD after chronic (1.34%; 95% CI: 1.00%, 1.68%) and acute (3.19%; 95% CI: 2.04%, 4.33%) intake. Reductions were seen in diastolic blood pressure (-1.60 mm Hg; 95% CI: -2.77, -0.43 mm Hg) and mean arterial pressure (-1.64 mm Hg; 95% CI: -3.27, -0.01 mm Hg). Evidence quality was low to moderate according to GRADE due to unclear reporting of allocation concealment, dropouts, missing outcome data, and biomarker heterogeneity.
Hooper L, Kay C, Abdelhamid A, et al. Am J Clin Nutr, 2012. PMID 22301923
2012 / Meta-analysis of randomized controlled trials
A meta-analysis of randomized controlled trials examined the effects of soy isoflavones on bone health in women. Isoflavone supplementation significantly increased bone mineral density by 54% and lowered the bone resorption marker urinary deoxypyridinoline by 23% compared to baseline. Effects were greater among postmenopausal women and with daily intakes exceeding 75 mg, whereas no significant changes occurred for serum bone alkaline phosphatase.
Wei P, Liu M, Chen Y, et al. Asian Pac J Trop Med, 2012. PMID 22305793
2012 / Systematic review of case reports and series
A systematic review evaluated 27 individual cases and case series encompassing 63 patients reported to have refeeding syndrome. Hypophosphatemia occurred in 26 of 27 patients (96%), while only 14 (51%) consistently displayed both low phosphorus and magnesium. In addition, hypocalcemia appeared in 7 patients (26%) and hyponatremia in 3 (11%), with no reports of hyperglycemia.
Skipper A Nutr Clin Pract, 2012. PMID 22307490
2012 / Taxonomy development and meta-regression of a Cochrane review
Researchers developed a taxonomy of 42 behaviour change techniques (BCTs) from guidance documents and treatment manuals to reduce excessive alcohol consumption (average inter-rater agreement of 80%). The taxonomy was applied to the Cochrane Review of brief alcohol interventions, and associations between BCTs and effectiveness were evaluated via meta-regression. Analyses showed that brief interventions that included the BCT 'prompt self-recording' were associated with larger effect sizes (P = 0.002).
Shows an association, not proof of cause and effect.
Michie S, Whittington C, Hamoudi Z, et al. Addiction, 2012. PMID 22340523
2012 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis evaluated 13 randomized controlled trials with 1,414 cancer patients who were malnourished or at risk of malnutrition. Oral nutritional interventions were associated with significant improvements in weight (mean difference = 1.86 kg, 95% CI = 0.25 to 3.47, P = .02) and energy intake (mean difference = 432 kcal/d, 95% CI = 172 to 693, P = .001), though these differences lost significance after removing main sources of heterogeneity. Interventions also benefited some QOL aspects (emotional functioning, dyspnea, loss of appetite, global QOL), but had no effect on mortality (RR = 1.06, 95% CI = 0.92 to 1.22, P = .43).
Baldwin C, Spiro A, Ahern R, et al. J Natl Cancer Inst, 2012. PMID 22345712
2012 / Meta-analysis of randomized controlled feeding trials
In a meta-analysis of six controlled feeding trials with 118 participants, small doses of fructose (up to 36 g/d) exchanging isoenergetically for other carbohydrates lowered HbA1c (MD -0.40, 95% CI -0.72 to -0.08) and decreased fasting glucose (MD -0.25, 95% CI -0.44 to -0.07). No adverse changes occurred in fasting insulin, body weight, triacylglycerols, or uric acid. The researchers noted that small trial numbers and short trial durations limited these conclusions.
Sievenpiper JL, Chiavaroli L, de Souza RJ, et al. Br J Nutr, 2012. PMID 22354959
2012 / Systematic review of randomized controlled trials
A review synthesized four randomized controlled trials involving 289 children and adolescents with epilepsy. The authors reported that available trials suggested the ketogenic regimen yielded short- to medium-term seizure control comparable to antiepileptic drugs. However, long-term adherence was hindered by substantial dropout rates caused by gastrointestinal symptoms and poor palatability. Trials examining adult populations or less restrictive options like the Atkins diet were minimal.
Levy RG, Cooper PN, Giri P Cochrane Database Syst Rev, 2012. PMID 22419282
2012 / Systematic review of randomised controlled trials
A systematic review searched multiple databases to evaluate the effectiveness of one-to-one dietary interventions delivered in dental care settings. Five randomized controlled trials met inclusion criteria; two were multi-intervention studies and three were single-intervention studies (one focused on dental caries and two on general health). Significant changes in dietary behaviour were reported for at least one primary outcome variable in four out of the five studies. The authors concluded there is some evidence that one-to-one dental setting interventions can change behaviour, with greater evidence for altering fruit/vegetable and alcohol intake than sugar consumption, though more methodologically rigorous studies are needed.
Harris R, Gamboa A, Dailey Y, et al. Cochrane Database Syst Rev, 2012. PMID 22419315